Use of smokeless tobacco and risk of myocardial infarction and stroke: Systematic review with meta-analysis

BMJ (Online)

Volumn 339, Issue 7719, 2009, Pages 502-

  Boffetta, Paolo ^a   Straif, Kurt ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DATA BASE; FATALITY; HEART INFARCTION; HUMAN; MASTICATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKELESS TOBACCO; STROKE; SWEDEN; SYSTEMATIC REVIEW; UNITED STATES;

FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; STROKE; TOBACCO, SMOKELESS;

EID: 69949091626     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3060     Document Type: Article

References (28)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 89. Smokeless tobacco products. Lyon: IARC, 2008.
2. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J 2006;3:37. (Pubitemid 46195766)
3. Broadstock M. Systematic review of the health effects of modified smokeless tobacco products. NZHTA Report 2007;10:1-129.
4. SCENIHR (Scientific Committee on Emerging and Newly-Identified Health Risks). Scientific opinion on the health effects of smokeless tobacco products. Brussels: European Commission, 2008. http://ec.europa.eu/health/ph-risk/ committees/04-scenihr/docs/scenihr-o-013.pdf.
5. Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol 2007,36:789-804.
6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000;283:2008-2012
7. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 1992;305:1252-1256
8. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as possible risk factor for myocardial infarction: a population-based study in middle-aged men. J AmColl Cardiol 1999;34:1784-1790
9. Accortt NA,Waterbor JW, Beai C, Howard G. Chronic diseasemortality in a cohort of smokeless tobacco users. Am J Epidemiol 2002;156:730-737 (Pubitemid 35155179)
10. Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men. A nested case-control study. Stroke 2003;34:1754-1759
11. Henley SJ, ThunMJ, Connell C, Calle EE. Twolarge prospective studies of mortality among men who use snuff or chewing tobacco. Cancer Causes Control 2005;16:347-358
12. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiol 2005;16:12-16 (Pubitemid 40239273)
13. Haglund B, Eliasson M, Stenbeck M, Rosén M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scan J Publ Health 2007;35:618-622 (Pubitemid 350176909)
14. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction among men. J Intern Med 2007;262:351-359 (Pubitemid 47246970)
15. Wennberg P, Eliasson M, Hallmans G, Johansson L, Booman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J InternMed 2007;262:360-367 (Pubitemid 47246968)
16. Hergens MP, Lambe M, Pershagen G, Terent A, Ye W. Use of smokeless tobacco and the risk of stroke among Swedish men. Epidemiol 2008;19:794-799
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
18. StataCorp LP. Intercooled Stata 9.1 for Windows. College Station, TX: StataCorp, 2005.
19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101
20. Greenland S, O'Rourke K. Meta-analysis. In: Rothman KJ, Greenland S, Lash TL, eds. Modern epidemiology, 3rd edn. Philadelphia, Pa: Lippincott Williams & Wilkins, 2008:652-682
21. Giovino GA, Schooley MW, Zhu BP, Chrismon JH, Tomar SL, Peddicord JP, et al. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. MMWR CDC Surveill Summ 1994;43:1-43.
22. Folkhälsa. Lägesrapport 2005. Stockholm: Socialstyrelsen, 2006:24. www.socialstyrelsen.se/Publicerat/2006/9081/2006-131-7.htm.
23. World Health Organization. Mortality database. Geneva:WHO, 2008. www.who.int/healthinfo/morttables/en/index.html.
24. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998:115-134
25. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil 2004;11:101-112 (Pubitemid 38591080)
26. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res 2003;5:561-569
27. Rodu B, Stegmayr B, Nasic S, Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J InternMed 2002;252:398-404. (Pubitemid 36706571)
28. Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 2005;33:321-324